Clinical Trial Update: Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome [Phase 3]

View source ↗

Summary

Phase 3 study comparing duloxetine to placebo for fibromyalgia has completed. Sponsor is Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED